879 November 2015, Vol. 105, No. 11 NOVEMBER 2015 VOL. 105 NO. 11
GUEST EDITORIAL
881 Vaccination saves lives – dare we allow the anti-vaccine lobbyists to prevent it?
L Baker
882 EDITOR’S CHOICE CORRESPONDENCE 884 Modelling cost-effective therapies
R P Abratt
884 Junior medical researchers: A neglected community with great academic potential J Bovijn, A Jacobs, M T Boswell, E du Bruyn, L Bovijn, N Berkowitz
IZINDABA
886 Motsoaledi on ‘tide-turning’ new HIV treatment guidelines 887 Medical aids often their own worst enemies with fraud
889 Council for Medical Schemes braves the tightrope between funders and the poor 890 Private hospitals could turbo-boost public sector reform
BOOK REVIEW
891 The Practitioner’s Guide to Medical Malpractice in South African Law SAMJ FORUM
COCHRANE CORNER
892 Interventions for improving childhood vaccination coverage in low- and middle-income countries
C S Wiysonge, T Young, T Kredo, M McCaul, J Volmink HEALTHCARE DELIVERY
894 Appropriate indications for positron emission tomography/computed tomography:
College of Nuclear Physicians of the Colleges of Medicine of South Africa M Sathekge, J M Warwick, A Doruyter, M Vorster
CLINICAL ALERT
897 Efavirenz as a cause of ataxia in children M P K Hauptfleisch, D P Moore, J L Rodda OPINION
899 Child research in South Africa: How do the new regulations help?
A E Strode, C M Slack EDITORIALS
901 Screening for childhood hearing impairment in resource-constrained settings:
Opportunities and possibilities L Petersen, L Ramma
902 Time for ‘basic antenatal care plus’ in South Africa?
G J Hofmeyr, L Mentrop
904 Family planning in South Africa: Missing essentials and desirables N D Goldstuck
905 Patents and the quality, safety and efficacy of medicines K du Toit, W du Preez, S Padayachee
REVIEW
907 Pre-exposure prophylaxis for South African adolescents: What evidence?
L-G Bekker, K Gill, M Wallace RESEARCH
912 School-based human papillomavirus vaccination: An opportunity to increase knowledge about cervical cancer and improve uptake of screening
G Dreyer, F H van der Merwe, M H Botha, L C Snyman, D Constant, C Visser, J Harvey
SAMJ
EDITOR-IN-CHIEF
Janet Seggie, BSc (Hons), MD (Birm), FRCP (Lond), FCP (SA)
DEPUTY EDITOR
Bridget Farham, BSc (Hons), PhD, MB ChB EDITORS EMERITUS
Daniel J Ncayiyana, MD (Groningen), FACOG, MD (Hon), FCM (Hon) JP de V van Niekerk, MD, FRCR ASSOCIATE EDITORS
Q Abdool Karim, A Dhai, N Khumalo, R C Pattinson, A Rothberg, A A Stulting, J Surka, B Taylor, M Blockman HMPG
CEO AND PUBLISHER Hannah Kikaya
Email: [email protected] MANAGING EDITOR Ingrid Nye TECHNICAL EDITORS Emma Buchanan Paula van der Bijl NEWS EDITOR
Chris Bateman | Email: [email protected] PRODUCTION MANAGER
Emma Jane Couzens DTP & DESIGN Carl Sampson
HEAD OF SALES AND MARKETING Diane Smith | Tel. 012 481 2069 Email: [email protected] JOURNAL ADVERTISING Charles Duke Benru de Jager Reneé van der Ryst Ladine van Heerden ONLINE SUPPORT
Gertrude Fani | Tel. 072 635 9825 Email: [email protected] FINANCE
Tshepiso Mokoena HMPG BOARD OF DIRECTORS Prof. M Lukhele (Chair), Dr M R Abbas, Dr M J Grootboom, Mrs H Kikaya, Adv. Y Lemmer, Prof. E L Mazwai, Dr M Mbokota, Mr G Steyn, Dr G Wolvaardt
ISSN 0256-9574
SAMA website: www.samedical.org Journal website: www.samj.org.za
For further product information contact PHARMA DYNAMICS P O Box 30958 Tokai Cape Town 7966
Tel 021 707 7000 Fax 021 701 5898 Email [email protected] CUSTOMER CARE LINE 0860 PHARMA (742 762) www.pharmadynamics.co.za Carzin XL. Each fi lm coated tablet contains 4 mg doxazosin. Reg. No.: RSA S3 41/7.1/0557. NAM NS2 10/34/0376. For full prescribing information, refer to the package insert approved by the Medicines Control Council, July 2009.
1) Pompeo ACL, et al. A randomised, double blind study comparing the effi cacy and tolerability of controlled release Doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia. Int J. Clin Pract Oct 2006;60(10):1172- 1177. 2) Kirby RS, et al. A Combined analysis of double-blind trials of the effi cacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia. British Journal of Urology International 2001 Feb;87(3):192-200. 3) Carzin XL package insert. 4) Vs. Doxazosin XL originator 4 mg modifi ed release formulation. Department of Health website.http://www.mpr.gov.za - Accessed 21/05/2015.
CLXC73/01/2015
DOXAZOSIN 4 mg
onset for consistent fl ow 1 Slower
A slower onset of action vs IR formulations to allow fewer titration steps and to minimize side-eff ects
2.
Eff ective treatment for urinary outfl ow obstruction and BPH symptoms
3.
Safe BPH treatment for normotensive and hypertensive patients
3.
Carzin XL , the extended release doxazosin off ers:
SAVING
450 %
MORE THAN
A Lupin Group Company
CarzinXL A4 Sept2015.indd 1 2015/10/13 9:49 AM
880 November 2015, Vol. 105, No. 11
Zebra mother and foal.
Photo: Susan Flegg
917 Missed opportunities for immunisation in health facilities in Cape Town, South Africa*
N Jacob, D Coetzee
922 A profile of anti-vaccination lobbying on the South African internet, 2011 - 2013*
R J Burnett, L J von Gogh, M H Moloi, G François
927 Age of diagnosis of congenital hearing loss: Private v. public healthcare sector*
I R T Butler, D Ceronio, T Swart, G Joubert
930 Evaluation of fetal MRI in a South African referral centre*
A Daire, S Andronikou, A Boutall, S Constantatos, C Stewart, S E Candy
934 Depressive and post-traumatic stress symptoms following termination of pregnancy in South African women: A longitudinal study measuring the effects of chronic burden, crisis support and resilience*
U Subramaney, G E Wyatt, J K Williams, M Zhang, H H Liu, D Chin 939 Childhood cancer incidence in South Africa, 1987 - 2007*
D C Stefan, D K Stones, R D Wainwright, M Kruger, A Davidson, J Poole, G P Hadley, D Forman, M Colombet, E Steliarova-Foucher
CONTINUING MEDICAL EDUCATION GUEST EDITORIAL
948 Adolescent health Q Abdool Karim REVIEW
948 Improving adolescent maternal health C Baxter, D Moodley
ARTICLES
952 Understanding and responding to HIV risk in young South African women:
Clinical perspectives*
R Dellar, A Waxman, Q Abdool Karim
953 Adolescent antiretroviral management: Understanding the complexity of non-adherence*
K Naidoo, A Munsami, M Archary
953 Adolescent HIV treatment issues in South Africa*
H Dawood
954 Human papillomavirus (HPV) vaccination of adolescents in the South African private health sector: Lessons from the HPV demonstration project in KwaZulu-Natal*
N Tathiah, M Naidoo, I Moodley
*Full article available online only.
PROFESSIONAL ADVERTISING CPD QUESTIONS
CONTENTS LISTED IN Index Medicus (Medline).
Excerpta Medica (EMBASE).
Biological Abstracts (BIOSIS).
Science Citation Index (SciSearch). Current Contents/Clinical Medicine
SAMJ SUBSCRIPTION RATES Local subscriptions R1 248.00 p.a.
Foreign subscriptions R2 832.00 p.a.
Single copies R104.00 local, R236.00 foreign Members of the Association receive the SAMJ only on request, as part of their membership benefit.
Subscriptions: Tel. 012-481-2071 E-mail: [email protected] The SAMJ is published monthly by the Health and Medical Publishing Group (Pty) Ltd, Co. registration 2004/0220 32/07, a subsidiary of SAMA.
Suites 9 & 10, Lonsdale Building, Gardner Way, Pinelands, 7405 Tel. 072 635 9825
E-mail: [email protected] Please submit all letters and articles for publication online at www.samj.org.za
© Copyright: Health and Medical Publishing Group (Pty) Ltd, a subsidiary of the South African Medical Association Use of editorial material is subject to the Creative Commons Attribution – Noncommercial Works License.
http://creativecommons.org/licenses/by- nc/3.0
Plagiarism is defined as the use of another’s work, words or ideas without attribution or permission, and representation of them as one’s own original work. Manuscripts containing plagiarism will not be considered for publication in the SAMJ. For more information on our plagiarism policy, please visit http://www.samj.org.za/
index.php/samj/about/editorialPolicies Printed by TANDYM PRINT
